http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106267419-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3616 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3692 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36 |
| filingDate | 2016-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106267419-B |
| titleOfInvention | HIV immunologic purging device |
| abstract | A kind of HIV immunologic purging device for medical domain, it is characterized in that the separator of preparation energy separated plasma and haemocyte, former macrophage feature was not only retained with hybridoma technology preparation but also the hybridoma macrophage strain of energy indeterminate growth, building CD4+T cell strain is transfected using foreign gene and is expanded by growth stimulant of the peculiar molecular antibody in its surface, the cell strain of preparation is formulated in cells frozen storing liquid, clarifier is formed with the container pack of high-biocompatibility material preparation, make cell concentration up to 80%, sealing, it is frozen for a long time in -196 DEG C of liquid nitrogen spare, macrophage strain therein and CD4+T cell strain play absorption HIV and are used, made clarifier is applied in combination with separator and regulatory process, blood in extracorporal circulatory system is divided into blood plasma and haemocyte by separator, the purified device of blood plasma filter out after HIV with Haemocyte converges, and then feeds back. |
| priorityDate | 2016-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 297.